Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-018976
Filing Date
2023-05-09
Accepted
2023-05-08 18:29:46
Documents
94
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20230331.htm   iXBRL 10-Q 2604624
2 EX-10.1 axsm-ex10_1.htm EX-10 593467
3 EX-10.2 axsm-ex10_2.htm EX-10 927733
4 EX-10.3 axsm-ex10_3.htm EX-10 416864
5 EX-31.1 axsm-ex31_1.htm EX-31 18640
6 EX-31.2 axsm-ex31_2.htm EX-31 18454
7 EX-32.1 axsm-ex32_1.htm EX-32 8541
8 EX-32.2 axsm-ex32_2.htm EX-32 8527
  Complete submission text file 0000950170-23-018976.txt   12475971

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axsm-20230331.xsd EX-101.SCH 76710
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axsm-20230331_lab.xml EX-101.LAB 584952
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axsm-20230331_cal.xml EX-101.CAL 60968
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axsm-20230331_pre.xml EX-101.PRE 437957
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axsm-20230331_def.xml EX-101.DEF 240652
88 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20230331_htm.xml XML 1861982
Mailing Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 23899374
SIC: 2834 Pharmaceutical Preparations